Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys
Autore:
Linn, GS; Javitt, DC;
Indirizzi:
Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA Nathan S Kline Inst Psychiat Res Orangeburg NY USA 10962 rg, NY 10962 USA
Titolo Testata:
NEUROREPORT
fascicolo: 1, volume: 12, anno: 2001,
pagine: 117 - 120
SICI:
0959-4965(20010122)12:1<117:P(DOPI>2.0.ZU;2-2
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACOUSTIC STARTLE RESPONSE; ANIMAL-MODEL; SCHIZOPHRENIA; REFLEX; RATS; CLOZAPINE; KETAMINE;
Keywords:
NMDA receptor; non-human primate model; phencyclidine (PCP); prepulse inhibition (PPI); psychotomimetic; schizophrenia; sensorimotor gating;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
21
Recensione:
Indirizzi per estratti:
Indirizzo: Linn, GS Nathan S Kline Inst Psychiat Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA Nathan S Kline Inst Psychiat Res 140 Old Orangeburg Rd Orangeburg NY USA 10962
Citazione:
G.S. Linn e D.C. Javitt, "Phencyclidine (PCP)-induced deficits of prepulse inhibition in monkeys", NEUROREPORT, 12(1), 2001, pp. 117-120

Abstract

Prepulse inhibition (PPI) of the acoustic startle reflex is a measure of sensorimotor gating which occurs in both rodents and humans. PPI is deficient in severe neuropsychiatric disorders such as schizophrenia. We investigated PPI in 10 adult monkeys (Cebus apella). Stimuli were 115 dB white noise startle pulses, either alone or preceded by 120 ms with a prepulse of either 8 or 16 dB above the 70 dB background noise. Experiments included a pretreatment baseline session and a session following treatment with either phencyclidine (PCP, 0.12 mg/kg, i.m.) or saline. Comparison of peak amplitudes indicated a significant intensity-dependent decrease in startle response that was similar to that observed in humans under similar experimental conditions. PCP treatment significantly disrupted PPI, but did not reduce responses to startle pulses alone. These results provide the first demonstration of PPI in monkeys. The ability of PCP to induce schizophrenia-like deficits in PPI suggests that PPI in nonhuman primates may provide an important animal model for the development of novel anti-schizophrenia medications. NeuroReport 12:117-120 (C) 2001 Lippincott Williams & Wilkins.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/20 alle ore 01:25:36